Skip to content

ABBV

AbbVie Inc.

EBITDA, 2025
$23.2B
YoY, 2025
+32.5%
5-year CAGR
+5.4%
10-year CAGR
+10.7%

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025$23.2B+32.5%
2024$17.5B−18.3%
2023$21.5B−19.3%
2022$26.6B+0.5%
2021$26.4B+48.3%
2020$17.8B+18.9%
2019$15.0B+84.1%
2018$8.1B−26.2%
2017$11.0B+4.9%
2016$10.5B+25.7%
2015$8.4B+99.5%
2014$4.2B−36.0%
2013$6.6B−5.8%
2012$7.0B+42.4%
2011$4.9B—